Genprex (GNPX) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…

Genprex (GNPX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: February 14, 2025 (17:28)

Sector: Healthcare

The share price of Genprex, Inc. (GNPX) now

Latest session on the 13th of February for
Genprex, Inc. is negative
Trading Volume: 16746963
Open: 0.535 /  High: 0.549 /  Low: 0.41
Current value: $0.471
What analysts predict: $7.5
52-week High/Low: $5.41 / $0.281
50-Day Moving Average: $0.833 — resistance level today
200-Day Moving Average: $1.373 — resistance level today

Are you interested in Genprex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Genprex stock price in 2025, 2026, 2027. How much will one Genprex share be worth in 2025 - 2027?

When should I take profit in Genprex stock? When should I record a loss on Genprex stock? What are analysts' forecasts for Genprex stock? What is the future of Genprex stock? We forecast Genprex stock performance using neural networks based on historical data on Genprex stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Genprex stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Genprex shares. This happens once a day.


Historical and forecast chart of Genprex stock

The chart below shows the historical price of Genprex stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Genprex stock price can be found in the table below.

Long-term forecasts by years.

Genprex, Inc. Is a clinical gene therapy company. The company is focused on developing oncology based on its new technology platform, including its initial candidate product, Oncoprex, immunogenotherapy or Oncoprex. Oncoprex consists of a tumor suppressor gene introduced into the cells of a patient, which has an immunomodulatory effect and is thus considered an immunogenic therapy. The gene is one of a number of genes licensed for therapeutic use by the University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing preclinical gene therapy licensed by the University of Pittsburgh Commonwealth Higher Education System, which has the potential to treat type 1 and type 2 diabetes. He is developing his candidate product for use with targeted therapy and immunotherapy for non-small cell lung cancer (NSCLC).

Trending Themes in the Healthcare Sector

Genprex daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 16 0.72 0.60 0.82 38.33
Feb 17 0.58 0.28 0.74 163.00
Feb 18 0.30 0.18 0.35 93.63
Feb 19 0.33 0.26 0.44 72.36
Feb 20 0.32 0.16 0.45 179.84
Feb 21 0.36 0.21 0.50 139.80
Feb 22 0.46 0.32 0.59 84.23
Feb 23 0.45 0.34 0.63 85.33
Feb 24 0.54 0.41 0.64 56.60
Feb 25 0.49 0.35 0.59 67.99
Feb 26 0.44 0.25 0.61 149.10
Feb 27 0.33 0.24 0.44 85.70
Feb 28 0.53 0.27 0.65 139.51
Mar 01 0.55 0.39 0.70 78.29
Mar 02 0.53 0.43 0.60 38.63
Mar 03 0.83 0.64 1.07 65.92
Mar 04 1.05 0.67 1.54 129.80
Mar 05 0.94 0.69 1.06 53.58
Mar 06 0.41 0.25 0.63 145.50
Mar 07 0.15 0.08 0.22 182.18
Mar 08 0.16 0.10 0.23 138.94
Mar 09 0.17 0.10 0.24 137.46
Mar 10 0.15 0.09 0.22 138.94
Mar 11 0.24 0.18 0.29 62.36
Mar 12 0.29 0.21 0.35 66.46
Mar 13 0.32 0.21 0.40 87.39
Mar 14 0.35 0.25 0.52 107.29
Mar 15 0.28 0.23 0.38 64.14
Mar 16 0.34 0.28 0.52 89.54
Mar 17 0.34 0.28 0.50 77.26

Genprex Daily Price Targets


Genprex Stock Forecast 02-16-2025.

Forecast target price for 02-16-2025: $0.72.
Positive dynamics for Genprex shares will prevail with possible volatility of 27.708%.
Pessimistic target level: 0.60
Optimistic target level: 0.82

Genprex Stock Forecast 02-17-2025.

Forecast target price for 02-17-2025: $0.58.
Negative dynamics for Genprex shares will prevail with possible volatility of 61.977%.
Pessimistic target level: 0.28
Optimistic target level: 0.74

Genprex Stock Forecast 02-18-2025.

Forecast target price for 02-18-2025: $0.30.
Negative dynamics for Genprex shares will prevail with possible volatility of 48.356%.
Pessimistic target level: 0.18
Optimistic target level: 0.35

Genprex Stock Forecast 02-19-2025.

Forecast target price for 02-19-2025: $0.33.
Positive dynamics for Genprex shares will prevail with possible volatility of 41.983%.
Pessimistic target level: 0.26
Optimistic target level: 0.44

Genprex Stock Forecast 02-20-2025.

Forecast target price for 02-20-2025: $0.32.
Negative dynamics for Genprex shares will prevail with possible volatility of 64.266%.
Pessimistic target level: 0.16
Optimistic target level: 0.45

Genprex Stock Forecast 02-21-2025.

Forecast target price for 02-21-2025: $0.36.
Positive dynamics for Genprex shares will prevail with possible volatility of 58.298%.
Pessimistic target level: 0.21
Optimistic target level: 0.50

GNPX (GNPX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Mar. 1.90 -7.42 5.23 241.82
Apr. 14.42 -18.89 71.97 126.25
May. 29.56 -119.44 186.85 163.92
Jun. 15.08 -69.36 96.35 171.99
Jul. 63.63 -154.62 215.07 171.89
Aug. 28.00 -34.72 127.95 127.13
Sep. 200.46 -262.60 1 098.51 123.91
Oct. -487.12 -2 192.02 569.92 484.62
Nov. -759.90 -3 898.28 2 272.10 271.57
Dec. -4 749.37 -11 398.50 7 551.49 250.94

Genprex forecast for this year


Genprex Stock Prediction for Mar 2025

An uptrend is forecast for this month with an optimal target price of $1.90263. Pessimistic: $-7.42. Optimistic: $5.23


Genprex Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $14.4219. Pessimistic: $-18.89. Optimistic: $71.97


Genprex Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $29.5649. Pessimistic: $-119.44. Optimistic: $186.85


Genprex Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $15.0781. Pessimistic: $-69.36. Optimistic: $96.35


Genprex Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $63.6296. Pessimistic: $-154.62. Optimistic: $215.07


Genprex Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $27.997. Pessimistic: $-34.72. Optimistic: $127.95


Genprex Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $200.459. Pessimistic: $-262.60. Optimistic: $1 098.51


Genprex Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $-487.115. Pessimistic: $-2 192.02. Optimistic: $569.92


Genprex Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $-759.899. Pessimistic: $-3 898.28. Optimistic: $2 272.10


Genprex Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $-4749.37. Pessimistic: $-11 398.50. Optimistic: $7 551.49



Genprex (GNPX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 24 839.20 -109 044.00 90 911.40 219.95
Feb -72 530.40 -448 238.00 125 478.00 457.22
Mar -6 527.74 -36 228.90 27 285.90 232.78
Apr 1 697.21 -797.69 6 092.99 113.09
May 5 142.55 -6 376.77 18 461.80 134.54
Jun 39 340.50 -125 890.00 177 032.00 171.11
Jul 270 663.00 -335 622.00 1 767 430.00 118.99
Aug 592 752.00 -1 689 340.00 3 331 260.00 150.71
Sep 675 737.00 -3 108 390.00 2 757 010.00 212.74
Oct -2 919 180.00 -10 684 200.00 10 158 800.00 205.17
Nov 2 802 420.00 -5 240 520.00 12 807 000.00 140.92
Dec -728 628.00 -4 553 930.00 1 413 540.00 422.16

Genprex (GNPX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 138 439.00 -65 066.50 729 575.00 108.92
Feb 1 078 440.00 -1 865 710.00 4 173 570.00 144.70
Mar 4 173 570.00 -6 051 680.00 17 612 500.00 134.36
Apr -5 175 230.00 -17 492 300.00 22 719 300.00 176.99
May -21 839 500.00 -73 817 400.00 65 300 000.00 213.04
Jun 17 908 400.00 -23 460 000.00 95 630 700.00 124.53
Jul 44 233 700.00 -194 186 000.00 130 932 000.00 248.31
Aug 155 702 000.00 -596 340 000.00 395 484 000.00 250.79
Sep 460 879 000.00 -1 087 680 000.00 2 783 710 000.00 139.07
Oct 9 217 590.00 -19 172 600.00 33 091 100.00 157.94
Nov 58 900 400.00 -68 913 400.00 314 528 000.00 121.91
Dec 161 976 000.00 -529 662 000.00 490 787 000.00 207.92

Genprex information and performance

Genprex Address

100 CONGRESS AVENUE, SUITE 2000, AUSTIN, TX, US

Market Capitalization: 4 317 000 $

Market capitalization of the Genprex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GNPX shares in the company outstanding by the market price of one share.

EBITDA: -26 275 956 $

EBITDA of Genprex is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -10.69

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.182

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 8508100

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Genprex Stock)

Should I Buy Genprex Shares in 2025 year?

The maximum forecasted share price for next year is $2 802 415.75, which is $2 802 415.28 higher than the current stock price. By investing in Genprex shares today for a one-year period, you could achieve a profit of 594 992 628.24%. With an investment horizon of up to two years, the target share price is $460 879 328.00. resulting in a profit of 97 851 237 267.30% ($460 879 327.53 per share).

Does Genprex pay dividends?

No, it does not

Which economic sector do Genprex's shares belong to?

Genprex's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Genprex's shares?

You can view all the stocks that are part of the same sector as Genprex's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.